Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$3.1B |
| 2 |
Intel
INTC
|
+$1.53B |
| 3 |
Salesforce
CRM
|
+$1.14B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$799M |
| 5 |
Mastercard
MA
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$2.22B |
| 2 |
Toronto Dominion Bank
TD
|
+$2.1B |
| 3 |
PNC Financial Services
PNC
|
+$1.84B |
| 4 |
General Motors
GM
|
+$1.41B |
| 5 |
UnitedHealth
UNH
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 12.42% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
DT Midstream
DTM
$13.9B
| $99.4M | 0.03% |
2,014,043
-1,528,597
| -43% | -$79.2M |
|
277
Willis Towers Watson
WTW
$31.5B
| $98.6M | 0.03% |
424,263
+295
| +0.1% | +$71.3K |
|
278
Corebridge Financial
CRBG
$15.1B
| $98.4M | 0.03% |
6,143,519
+717,317
| +13% | +$14.1M |
|
279
Infosys
INFY
$49.6B
| $95.4M | 0.03% |
5,472,860
-13,659
| -0.2% | -$249K |
|
280
MACOM Technology Solutions
MTSI
$24.1B
| $94.2M | 0.03% |
1,330,000
| – | – |
|
281
PPG Industries
PPG
$25.5B
| $94.2M | 0.03% |
705,027
+477
| +0.1% | +$61.5K |
|
282
Brookfield Infrastructure
BIPC
$4.97B
| $94.1M | 0.03% |
2,041,018
| – | – |
|
283
CoStar Group
CSGP
$12.8B
| $92.5M | 0.03% |
1,343,831
+726,394
| +118% | +$53.6M |
|
|
OSH
284
DELISTED
Oak Street Health, Inc.
OSH
| $87.8M | 0.03% |
2,269,001
-14,053,946
| -86% | -$454M |
|
|
ATVI
285
DELISTED
Activision Blizzard
ATVI
| $86.6M | 0.02% |
1,012,118
+505
| +0% | +$39.2K |
|
286
GFL Environmental
GFL
$14.9B
| $85.6M | 0.02% |
2,485,774
+885,774
| +55% | +$28M |
|
287
Extra Space Storage
EXR
$31.4B
| $85.2M | 0.02% |
523,186
-131
| -0% | -$20.6K |
|
288
Novartis
NVS
$289B
| $83.1M | 0.02% |
902,835
-81,573
| -8% | -$7.12M |
|
289
Nutrien
NTR
$32B
| $82.6M | 0.02% |
1,118,601
+541
| +0% | +$41.7K |
|
290
Coupang
CPNG
$29B
| $82M | 0.02% |
5,123,588
-862,875
| -14% | -$13.4M |
|
291
Silicon Laboratories
SLAB
$7.31B
| $81.2M | 0.02% |
464,000
| – | – |
|
292
Fastenal
FAST
$59.7B
| $78.5M | 0.02% |
2,909,102
+1,010
| +0% | +$25.9K |
|
293
New York Times
NYT
$10.4B
| $78.3M | 0.02% |
2,014,638
+100,000
| +5% | +$3.69M |
|
294
Levi Strauss
LEVI
$8.63B
| $78.3M | 0.02% |
4,295,300
| – | – |
|
|
PCH
295
DELISTED
PotlatchDeltic
PCH
| $78.1M | 0.02% |
1,576,968
+286,768
| +22% | +$13.5M |
|
296
Extreme Networks
EXTR
$3.26B
| $76.9M | 0.02% |
4,021,775
-4,894,535
| -55% | -$90.3M |
|
297
Fortive
FTV
$18.5B
| $74M | 0.02% |
1,439,795
| – | – |
|
298
SiriusPoint
SPNT
$2.68B
| $73.2M | 0.02% |
9,000,000
+150,000
| +2% | +$1.05M |
|
|
BRSL
299
Brightstar Lottery PLC
BRSL
$2.19B
| $73.2M | 0.02% |
2,729,850
+185,701
| +7% | +$4.76M |
|
300
US Bancorp
USB
$102B
| $72.3M | 0.02% |
2,006,319
+960
| +0% | +$42.8K |
|
Similar funds
Capital Research Global Investors's Q1 2023 Portfolio in Review
As of Q1 2023, Capital Research Global Investors held 458 positions worth $350B, up 5.9% from $331B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q1 2023 filing shows 22 new, 178 increased, 161 reduced and 33 closed positions. Its largest new stake was GE HealthCare: 43,443,782 shares worth $3.56B. The largest sale was GE Aerospace, an estimated $2.22B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q1 2023 buy was GE HealthCare: 43,443,782 shares worth $3.56B.
- Capital Research Global Investors added most to Salesforce in Q1 2023, an estimated $1.14B increase.
- Capital Research Global Investors's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $2.22B.
- Capital Research Global Investors fully exited First Republic Bank in Q1 2023, selling an estimated $346M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $350B portfolio in Q1 2023.
- Capital Research Global Investors opened 22 new positions and closed 33 in Q1 2023.
- Capital Research Global Investors's portfolio value rose 5.9% quarter-over-quarter to $350B.
Based on Capital Research Global Investors's 13F filing for Q1 2023, filed 15 May 2023.